Empower: Access to Medince - Royal Society of Medicine
On 26th November Empower: Access to Medicine brought together the MHRA, Department of Health, charities, Peers, leading academics and campaigners for a discussion led by the President of the Royal Society of Medicine, Babulal Sethia, and Chairman of GW Pharmaceuticals, Geoffrey Guy.
The meeting received an update from Daniel O’Connor, MHRA, on the progress of the Early Access to Medicines Scheme, and featured a wide ranging discussion exploring the barriers to earlier access, financial hurdles in drug development, gaps in the relationship between health bodies, and the role of the patient voice.
President Babulal Sethia
Geoffrey Guy, GW Pharmaceuticals
Daniel O'Connor, Medicines and Healthcare products Regulatory Agency
Richard Carter, Department of Health
Aisling Burnand, Association of Medical Research Charities
Emily Crossley, Duchene’s Children’s Trust
Alex Johnson, Joining Jack
Richard Barker, Centre for the Advancement of Sustainable Medical Innovation
Pamela Learmonth, BioIndustry Association
Jennifer Bryant Pearson, Empower: Access to Medicine
James Hargrave, Empower: Access to Medicine
Jeremy King, Obillex
Jack Scannell, Centre for the Advancement of Sustainable Medical Innovation
Martin Smith, NHS
Alastair Kent, Genetic Alliance UK
Dr Hollie Chandler, Cancer Research UK
Caroline Brocklehurst, Teenage Cancer Trust
Bina Rawal, Association of the British Pharmaceutical Industry
We look forward to sharing a comprehensive report on the discussion’s conclusions and next steps for the campaign in due course.